Philipp Blanke

Showing 1-18 of 18 articles

Interventions for valvular disease

Early outcomes of transcatheter mitral valve replacement with the Tendyne system in severe mitral annular calcification

Gössl M, Thourani V, Babaliaros V, Conradi L, Chehab B, Dumonteil N, Badhwar V, Rizik D, Sun B, Bae R, Guyton R, Chuang M, Blanke P, Sorajja P

December 16, 2021 | 10.4244/EIJ-D-21-00745

Repeat transcatheter aortic valve implantation and implications for transcatheter heart valve performance: insights from bench testing

Sathananthan J, Fraser R, Landes U, Rich C, Sellers S, Leipsic J, Blanke P, Lutter G, Frank D, Puehler T, Wood D, Søndergaard L, Webb J

November 19, 2021 | 10.4244/EIJ-D-20-00697

Interventions for valvular disease

Risk of coronary obstruction and the need to perform BASILICA: the VIVID classification

Tang G, Komatsu I, Tzemach L, Simonato M, Wolak A, Blanke P, Dvir D

October 9, 2020 | 10.4244/EIJ-D-20-00067

Interventions for valvular disease

Reference dimensions of stented surgical aortic bioprostheses for valve size determination

Anastasius M, Godoy M, Weir-McCall J, Bapat V, Sathananthan J, Hensey M, Sellers S, Cheung A, Ye J, Wood D, Leipsic J, Webb J, Blanke P

August 7, 2020 | 10.4244/EIJ-D-19-00921

Interventions for valvular disease

Impact of implant depth on hydrodynamic function of the ALLEGRA bioprosthesis in valve-in-valve interventions

Sathananthan J, Fraser R, Kütting M, Hensey M, Landes U, Alkhodair A, Sedaghat A, Blanke P, Toggweiler S, Leipsic J, Søndergaard L, Wood D, Webb J

February 7, 2020 | 10.4244/EIJ-D-19-00782

Mitral regurgitation severity predicts one-year therapeutic benefit of Tendyne transcatheter mitral valve implantation

Badhwar V, Sorajja P, Duncan A, Thourani V, Schaefer U, Grayburn P, Dumonteil N, Babaliaros V, Garatti A, Lessick J, Chuang M, Blanke P, Muller D

December 20, 2019 | 10.4244/EIJ-D-19-00333

Interventions for valvular disease

Impact of implant depth on hydrodynamic function with the ACURATE neo transcatheter heart valve following valve-in-valve transcatheter aortic valve replacement in Mitroflow bioprosthetic valves: an ex vivo bench study

Sathananthan J, Sellers S, Fraser R, Dvir D, Hensey M, Murdoch D, Blanke P, Pibarot P, Toggweiler S, Wood D, Leipsic J, Webb J

May 20, 2019 | 10.4244/EIJ-D-18-00947

Interventions for valvular disease

First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system

Hensey M, Murdoch D, Sathananthan J, Alenezi A, Sathananthan G, Moss R, Blanke P, Leipsic J, Wood D, Cheung A, Ye J, Webb J

February 7, 2019 | 10.4244/EIJ-D-18-00935

Interventions for valvular disease

Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve

Kim U, Blanke P, Windecker S, Kasel M, Schäfer U, Walters D, Linke A, Le Breton H, Schymik G, Spence M, Søndergaard L, Abdel-Wahab M, Worthley S, Tchétché D, Reichenspurner H, Ohana M, Sellers S, Leipsic J

August 3, 2018 | 10.4244/EIJ-D-17-01040

Outcomes in patients with contained ruptures of the aortic annulus after transcatheter aortic valve implantation with balloon-expandable devices

Breitbart P, Minners J, Pache G, Blanke P, Reinöhl J, Hansson N, Nørgaard BL, Neumann F, Ruile P

December 20, 2017 | 10.4244/EIJ-D-17-00347

Interventions for valvular disease

Imaging for structural heart procedures: focus on computed tomography

Mooney J, Sellers S, Ohana M, Cavalcante J, Arepalli C, Grover R, Kim U, Selvakumar K, Blanke P, Leipsic J

September 24, 2017 | 10.4244/EIJ-D-17-00516

Interventions for valvular disease

Transcatheter aortic valve replacement with the Portico valve: one-year results of the early Canadian experience

Perlman G, Cheung A, Dumont E, Stub D, Dvir D, Del Trigo M, Pelletier M, Alnasser S, Ye J, Wood D, Thompson C, Blanke P, Leipsic J, Seidman M, LeBlanc H, Buller C, Rodés-Cabau J, Webb J

January 20, 2017 | 10.4244/EIJ-D-16-00299

Interventions for valvular disease

Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 1: systematic measurement methodology and inter-observer variability

Thériault-Lauzier P, Mylotte D, Dorfmeister M, Spaziano M, Andalib A, Mamane S, Chetrit M, Blanke P, Cecere R, Buithieu J, Martucci G, Tchétché D, Modine T, Van Mieghem N, Lange R, Windecker S, Bilodeau L, Leipsic J, Piazza N

October 10, 2016 | 10.4244/EIJY15M11_09

Interventions for valvular disease

Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 2: geometrical measurements in patients with functional mitral regurgitation

Thériault-Lauzier P, Dorfmeister M, Mylotte D, Andalib A, Spaziano M, Blanke P, Martucci G, Lange R, Leipsic J, Bilodeau L, Piazza N

October 10, 2016 | 10.4244/EIJY15M11_10

Interventions for valvular disease

Calcification of the aortic valve and mitral apparatus: location, quantification and implications for device selection

Leipsic J, Blanke P

September 18, 2016 | 10.4244/EIJV12SYA4

Interventions for valvular disease

Transcatheter aortic valve implantation in bicuspid aortic valve stenosis

Perlman G, Blanke P, Webb J

September 18, 2016 | 10.4244/EIJV12SYA10

Interventions for valvular disease

Transapical mitral valve implantation after unclipping of a MitraClip: a glimpse into the future and treatment considerations in mitral regurgitation

Dvir D, Cheung A, Boone R, Leipsic J, Blanke P, Perlman G, Moss R, Toma M, Stub D, Banai S, Webb J

June 10, 2016 | 10.4244/EIJV12I2A38

“Heart Team” decision making in elderly patients with symptomatic aortic valve stenosis who underwent AVR or TAVI – a look behind the curtain. Results of the prospective TAVI Calculation of Costs Trial (TCCT)

Kaier K, Gutmann A, Vach W, Sorg S, Siepe M, von zur Mühlen C, Moser M, Blanke P, Beyersdorf F, Zehender M, Bode C, Reinöhl J

November 20, 2015 | 10.4244/EIJY14M12_06

1

Latest news

Three-year TAVI outcomes for BAV vs TAV

FREE ARTICLE - Dao Zhou et al.

January 20, 2022

Percutaneous management of left ventricular assist device outflow graft obstruction

FREE ARTICLE - Aleksandra Gasecka et al.

January 19, 2022

EuroCTO Club Consensus on Dual Lumen Microcatheters for CTO Recanalisation; Predicting Radial Crossover in ACS, the MATRIX score; DAPT duration for BRS; and more…

December 17, 2021

Lipid-rich plaque density and LDL-C in statin-treated vs statin-naïve patients

FREE ARTICLE - Rebecca Torguson et al.

January 17, 2022

Redo transcatheter mitral valve replacement in mitral annular calcification

FREE ARTICLE - Jennifer Jdaidani et al

January 13, 2022

TAVI vs SAVR in bicuspid aortic valve stenosis

FREE ARTICLE - Monil Majmundar et al.

January 12, 2022

Management of MR patients undergoing TMVI screening

FREE ARTICLE - Sebastian Ludwig et al.

January 7, 2022

Valvular disease